Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PERTUZUMAB Cause Gamma-glutamyltransferase increased? 68 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Gamma-glutamyltransferase increased have been filed in association with PERTUZUMAB (PERJETA). This represents 0.3% of all adverse event reports for PERTUZUMAB.

68
Reports of Gamma-glutamyltransferase increased with PERTUZUMAB
0.3%
of all PERTUZUMAB reports
2
Deaths
35
Hospitalizations

How Dangerous Is Gamma-glutamyltransferase increased From PERTUZUMAB?

Of the 68 reports, 2 (2.9%) resulted in death, 35 (51.5%) required hospitalization, and 6 (8.8%) were considered life-threatening.

Is Gamma-glutamyltransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 68 reports have been filed with the FAERS database.

What Other Side Effects Does PERTUZUMAB Cause?

Diarrhoea (3,343) Off label use (1,886) Fatigue (1,672) Nausea (1,669) Myelosuppression (1,311) Disease progression (1,142) Vomiting (1,096) Dyspnoea (987) Neuropathy peripheral (983) Pyrexia (926)

What Other Drugs Cause Gamma-glutamyltransferase increased?

FINGOLIMOD (635) ACETAMINOPHEN (442) METHOTREXATE (421) ATORVASTATIN (376) RIBOCICLIB (375) LETROZOLE (323) DEXAMETHASONE (292) CYCLOPHOSPHAMIDE (277) CARBOPLATIN (262) NIVOLUMAB (261)

Which PERTUZUMAB Alternatives Have Lower Gamma-glutamyltransferase increased Risk?

PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB PERTUZUMAB vs PETROLATUM PERTUZUMAB vs PEVONEDISTAT PERTUZUMAB vs PEXIDARTINIB PERTUZUMAB vs PHENACETIN

Related Pages

PERTUZUMAB Full Profile All Gamma-glutamyltransferase increased Reports All Drugs Causing Gamma-glutamyltransferase increased PERTUZUMAB Demographics